Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $76,023 | 5 | 99.6% |
| Food and Beverage | $307.02 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. | $74,220 | 3 | $0 (2020) |
| Myovant Sciences Inc. | $1,500 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $427.50 | 2 | $0 (2023) |
| ImmunoGen, Inc. | $127.71 | 1 | $0 (2023) |
| Foundation Medicine, Inc. | $54.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $430.21 | 2 | AstraZeneca Pharmaceuticals LP ($302.50) |
| 2021 | $1,500 | 1 | Myovant Sciences Inc. ($1,500) |
| 2020 | $6,000 | 1 | MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. ($6,000) |
| 2019 | $1,000 | 1 | Mitsubishi Tanabe Pharma Development America, Inc. ($1,000) |
| 2018 | $67,220 | 1 | Mitsubishi Tanabe Pharma Development America, Inc. ($67,220) |
| 2017 | $179.31 | 2 | AstraZeneca Pharmaceuticals LP ($125.00) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $302.50 | General |
| 06/14/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $127.71 | General |
| Category: Oncology | ||||||
| 08/18/2021 | Myovant Sciences Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 01/27/2020 | MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 03/08/2019 | Mitsubishi Tanabe Pharma Development America, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/07/2018 | Mitsubishi Tanabe Pharma Development America, Inc. | — | Consulting Fee | Cash or cash equivalent | $67,220.00 | General |
| 10/24/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $54.31 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2017 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 374 | 540 | $86,755 | $18,031 |
| 2022 | 11 | 418 | 617 | $108,075 | $21,254 |
| 2021 | 12 | 496 | 781 | $146,790 | $29,957 |
| 2020 | 9 | 425 | 649 | $103,900 | $20,526 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2023 | 86 | 92 | $8,280 | $3,554 | 42.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 47 | 116 | $20,880 | $3,382 | 16.2% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Facility | 2023 | 40 | 49 | $9,680 | $2,581 | 26.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 17 | 30 | $12,150 | $2,054 | 16.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 14 | 64 | $5,440 | $1,501 | 27.6% |
| 88291 | Interpretation and report of genetic testing | Facility | 2023 | 48 | 50 | $5,750 | $1,386 | 24.1% |
| 88381 | Preparation of specimen, manual | Facility | 2023 | 55 | 56 | $10,920 | $1,079 | 9.9% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2023 | 26 | 26 | $6,500 | $897.52 | 13.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 15 | 29 | $4,495 | $829.74 | 18.5% |
| 88369 | Microscopic genetic analysis of tissue, manual, each additional procedure | Facility | 2023 | 26 | 28 | $2,660 | $766.38 | 28.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 67 | 162 | $29,160 | $5,072 | 17.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 34 | 44 | $17,820 | $3,066 | 17.2% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2022 | 57 | 62 | $5,580 | $2,400 | 43.0% |
| 88368 | Microscopic genetic analysis of tissue, manual, initial procedure | Facility | 2022 | 67 | 69 | $17,250 | $2,387 | 13.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 23 | 95 | $8,075 | $2,253 | 27.9% |
| 88369 | Microscopic genetic analysis of tissue, manual, each additional procedure | Facility | 2022 | 67 | 71 | $6,745 | $1,916 | 28.4% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 11 | 11 | $6,600 | $1,347 | 20.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 25 | 31 | $4,805 | $905.14 | 18.8% |
| 88291 | Interpretation and report of genetic testing | Facility | 2022 | 26 | 26 | $2,990 | $741.51 | 24.8% |
| 88381 | Preparation of specimen, manual | Facility | 2022 | 30 | 30 | $5,850 | $601.57 | 10.3% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 11 | 16 | $3,200 | $564.30 | 17.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 92 | 212 | $38,160 | $6,581 | 17.2% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2021 | 35 | 62 | $25,110 | $4,430 | 17.6% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2021 | 27 | 29 | $17,400 | $3,653 | 21.0% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2021 | 85 | 89 | $8,010 | $3,516 | 43.9% |
About Dr. Pei Hui, MD
Dr. Pei Hui, MD is a Anatomic Pathology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1538141882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pei Hui, MD has received a total of $76,330 in payments from pharmaceutical and medical device companies, with $430.21 received in 2023. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($76,023).
As a Medicare-enrolled provider, Hui has provided services to 1,713 Medicare beneficiaries, totaling 2,587 services with total Medicare billing of $89,768. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location New Haven, CT
- Active Since 11/14/2005
- Last Updated 07/08/2008
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1538141882
Products in Payments
- Elahere (Biological) $127.71
- LYNPARZA (Drug) $125.00
- FOUNDATIONONE (Device) $54.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New Haven
David Rimm, Md, MD
Anatomic Pathology — Payments: $909,236
Dr. Sihem Khelifa, M.d, M.D
Anatomic Pathology — Payments: $151,148
Dr. Sanja Dacic, Md,Phd, MD,PHD
Anatomic Pathology — Payments: $120,151
Mr. Demetrios Braddock, Md, MD
Anatomic Pathology — Payments: $68,859
Dhanpat Jain, Md, MD
Anatomic Pathology — Payments: $22,884
Carlo Bifulco, Md, MD
Anatomic Pathology — Payments: $18,942